Advertisement

Citation tools

Kumar, Shaji K. et al "Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma." Blood 125.3 (2015): 443-448. Web. 20 Oct. 2017.